About AirXpanders
AirXpanders is a publicly listed company based in Mountain View (United States) founded in 2006. Tissue expansion technology for breast reconstruction surgery is developed. AirXpanders has raised $36.15 million across 12 funding rounds from investors including GE Capital, Oxford Finance and Western Technology Investment. Its focus areas include Life Sciences, Women Health, Medical Devices and Therapy. Its legal entity is AIRXPANDERS INC. Its competitors include Sientra, BioAesthetics and Mpathy Medical Devices; 3 of its 3 listed competitors have raised funding.
Company details
AirXpanders was founded in 2006 and is based in Mountain View, United States. Medical devices for tissue expansion in post-mastectomy reconstructive surgery are developed, with a focus on breast reconstruction. The AeroForm expander is designed for patient control, allowing CO2 doses to be administered via a wireless device to gradually stretch skin tissue. This supports preparation for permanent implants in the reconstructive process.
- Headquarters Mountain View, United States
- Stage Public
- SectorsHealthcare
- Website airxpanders.com
- Social LinkedIn X
- Legal Name Axp Energy Limited
- Annual Revenue$532.25 K (USD)-14.85as on Jun 30, 2026
- Net Profit-$2.2 M (USD)46.86as on Jun 30, 2026
- EBITDA-$1.51 M (USD)21.07as on Jun 30, 2026
- Total Equity Funding$36.15M (USD)
in 12 rounds
- Latest Funding Round$3.4M (USD), Post-IPO
Sep 2018
- InvestorsGE Capital
& 6 more
Funding Insights of AirXpanders
AirXpanders has successfully raised a total of $36.15M across 12 strategic funding rounds. The most recent funding activity was a Post-IPO round of $3.4 million completed in September 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $36.15M
- Total Rounds 12
- Last Round Post-IPO — $3.4M
- First Round $5.61M
(Mar 2008)
- Investors Count 7
Latest 10 of 12 funding rounds of AirXpanders with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2018 | $3.4M | Post-IPO | – | – | |
| Aug 2017 | $15M | Debt – Conventional | – | – | – |
| Feb 2017 | $34.65M | Post-IPO | – | – | – |
| Jun 2016 | $14.89M | Post-IPO | – | – | – |
| Jun 2015 | $3M | Series E | – | – | – |
| Sep 2014 | $9.95M | Series E | – | – | – |
| Apr 2014 | $7M | Debt – Conventional | – | – | |
| May 2012 | $11.39M | Series D | – | Prolog Ventures, Heron Capital | |
| Feb 2011 | $3M | Debt – Conventional | – | – | |
| Apr 2010 | $5.45M | Series B | – | – |
7 investors in total: 7 institutional.
Investors in AirXpanders
AirXpanders has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include GE Capital, Oxford Finance and Western Technology Investment.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital and private equity firm | vivocapital.com | Palo Alto, United States | ||
| gbsventures.com.au | ||||
Health-focused venture capital investments are made in US sectors. | prologventures.com | Newark, United States | ||
Heron Capital is engaged in private equity investment management. | heroncap.com | Indianapolis, United States | ||
Venture debt is provided globally across multiple sectors. | 1980 | westerntech.com | Portola Valley, United States | |
Venture debt firm focused on the life sciences sector | 2002 | oxfordfinance.com | Alexandria, United States | |
Commercial aircraft and equipment leasing and lending services are provided. | 1932 | gecapital.com | United States |
Investor details for AirXpanders
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of AirXpanders
2 people are tracked at AirXpanders (1 in leadership, 1 in team).
| Name | Role | Group |
|---|---|---|
Frank Grillo | President and CEO | Leadership |
Soklin Eang | Medical Device | Team |
Complete people profiles for AirXpanders
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of AirXpanders
AirXpanders is a publicly listed company on the ASX with ticker symbol AXP in Australia, operating in the Energy minerals sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date20 Jul 2006
- Listed onASX: AXP
- Listed entityAXP ENERGY LIMITED
- Exchange sectorEnergy minerals
- ISINAU0000162950
- Share price0.00 AUD (-20% on the day) · 2026-10-14
- Market capitalisation2,248,668.00 AUD
- EPS (diluted, trailing year)-0.01 AUD
- Volume (last session)216,000
Financials of AirXpanders
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2026 | 772,830 AUD | -3.2M AUD | -2.2M AUD |
| 2025 | 907,610 AUD | -6.0M AUD | -2.8M AUD |
| 2024 | 981,460 AUD | -5.7M AUD | -1.9M AUD |
| 2023 | 710,170 AUD | -9.1M AUD | -2.5M AUD |
| 2022 | 28.6M AUD | 836,840 AUD | 4.5M AUD |
Detailed financial statements for AirXpanders
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of AirXpanders
4 dated milestones of AirXpanders across 12 years, from founding to its latest funding, stage changes and deals.
- Founded AirXpanders is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $5.6M.
- Funding Latest funding round, Post-IPO, of $3.4M.
Competitors of AirXpanders
AirXpanders has 3 listed competitors in our database, 3 of them funded. They include Sientra, BioAesthetics and Mpathy Medical Devices.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sientra.com | 2007 | Santa Barbara, United States | $150M | 304 | Products for plastic surgery and aesthetics are developed and marketed. | |
| bio-aesthetics.com | 2015 | New Orleans, United States | $7.4M | Tissue-engineered nipple-areolar complexes are developed for post-mastectomy use. | ||
| mpathymedical.com | 2003 | Raynham, United States | $5.4M | Surgical meshes for treating women's urinary incontinence are developed. |
Detailed competitors of AirXpanders
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of AirXpanders
Websites that share an audience with AirXpanders (airxpanders.com).
Websites whose visitors overlap most with AirXpanders. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bardbiopsy.com | 100% | View details | |||
memphisplasticsurgery.com | memphisplasticsurgery.com | 99% | #3,915,136 | – | |
| lifecell.com | 98% | View details | |||
amypare.com | amypare.com | 76% | #11,908,873 | – | |
breastreconstruction.vch.ca | breastreconstruction.vch.ca | 74% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 6 similar websites and full traffic analytics for AirXpanders
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Women's Health & Fertility
3 companies that operate in the same segment as AirXpanders (Women's Health & Fertility) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of cell-free DNA testing for oncology, women’s health, and organ health | 2004 | Redwood City, California, United States | USD 152.1 M | USD 2.31 B | 4,430 | |
Therapeutics for women's healthcare are developed and offered. | 1997 | Princeton, New Jersey, United States | USD 123.06 M | USD 19.59 M | ||
Provider of cell-free cancer liquid biopsy test | 2015 | San Francisco, California, United States | USD 388.62 M | 861 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Airxpanders
Complete news archive for AirXpanders
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AirXpanders
AirXpanders was founded in 2006 and raised its 1st funding round 2 years after it was founded.
AirXpanders is headquartered in Mountain View, United States. It is registered at Mountain View, California, United States.
AirXpanders is a funded company, having raised a total of $36.15M across 12 funding rounds to date. The company's 1st funding round was a Series B of $5.45M, raised on Mar 2008.
Annual revenue of AirXpanders is $532.25K as on Jun 30, 2026.
AirXpanders was founded in 2006 and is based in Mountain View, United States. Medical devices for tissue expansion in post-mastectomy reconstructive surgery are developed, with a focus on breast reconstruction. The AeroForm expander is designed for patient control, allowing CO2 doses to be administered via a wireless device to gradually stretch skin tissue. This supports preparation for permanent implants in the reconstructive process.
AirXpanders's top competitors include Sientra, BioAesthetics and Mpathy Medical Devices.
Yes, AirXpanders is publicly traded on ASX under the ticker symbol AXP.
AirXpanders has 7 investors. Key investors include GE Capital, Oxford Finance, Western Technology Investment, Vivo Capital, and GBS.
AirXpanders operates through Airxpanders Inc.